| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $199.6M | +53.3% |
| Cost of Revenue | $49.2M | +24.2% |
| Gross Profit | $150.4M | +66.1% |
| R&D Expense | $12.2M | +83.9% |
| SG&A Expense | $129.1M | +55.3% |
| Operating Income | $8.8M | +1946.9% |
| Pre-tax Income | -$17.3M | +27.0% |
| Income Tax | $161K | -77.0% |
| Net Income | -$17.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.2M | -36.2% |
| Short-term Investments | $8.7M | +0.0% |
| Accounts Receivable | $116.4M | +220.9% |
| Inventory | $10.7M | -1.5% |
| Current Assets | $189.7M | +36.0% |
| Total Assets | $389.0M | +24.6% |
| Current Liabilities | $91.3M | +85.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.2M | -678.2% |
| Capital Expenditures | $1.6M | +9.2% |
| Investing Cash Flow | -$33.2M | +78.3% |
| Financing Cash Flow | $28.5M | -77.5% |
| Free Cash Flow | -$23.8M | -1099.9% |
| +28.4% |
| EPS (Basic) | -$0.49 | +34.7% |
| EPS (Diluted) | -$0.49 | +34.7% |
| Long-term Debt |
| $262.7M |
| +6.5% |
| Total Liabilities | $319.7M | +32.2% |
| Stockholders' Equity | $69.7M | -1.6% |